NCT04825574View on ClinicalTrials.gov

Study for Patients Previously Treated in Avapritinib Clinical Trials

PHASE4CompletedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

May 21, 2021

Primary Completion Date

November 23, 2023

Study Completion Date

November 23, 2023

Conditions
Gastrointestinal Stromal Tumors
Interventions
DRUG

Avapritinib

avapritinib tablet

Trial Locations (1)

94800

Gustave Roussy Cancer Campus Grand Paris Institut de Cancerologie Gustave-Roussy, Villejuif

Sponsors
All Listed Sponsors
lead

Blueprint Medicines Corporation

INDUSTRY

NCT04825574 - Study for Patients Previously Treated in Avapritinib Clinical Trials | Biotech Hunter | Biotech Hunter